Key result
Hybrid left ventricular reconstruction using the Revivent TC anchoring system significantly reduced left ventricular end-systolic volume index from 73.2 ml at baseline to 56.1 ml at 5 years.
Why the study?
Evidence supporting surgical aneurysmectomy in ischemic heart failure is inconsistent, motivating evaluation of long-term outcomes with minimally invasive hybrid left ventricular reconstruction.
Does hybrid transcatheter and minithoracotomy left ventricular reconstruction reduce left ventricular end-systolic volume index in patients with ischemic cardiomyopathy?
Does hybrid transcatheter and minithoracotomy left ventricular reconstruction reduce left ventricular end-systolic volume index in patients with ischemic cardiomyopathy?
Effect estimate: 31% relative reduction
Absolute Event Rate: 56.1% vs 73.2%
p-value: p=0.047
Hybrid left ventricular reconstruction using the Revivent TC system provides significant and durable LV volume reduction over 5 years in patients with ischemic cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Supports durable LV volume reduction to 5 years in ischemic cardiomyopathy; hypothesis-generating pending randomized outcome trials.
Naar et al. (2021) studied Ischemic cardiomyopathy (n=23). Hybrid transcatheter and minithoracotomy left ventricular reconstruction (Revivent TC) vs. Baseline was evaluated on Reduction of left ventricular end-systolic volume index (LVESVI) at 5 years (31% relative reduction, p=0.047). Hybrid left ventricular reconstruction using the Revivent TC anchoring system significantly reduced left ventricular end-systolic volume index from 73.2 ml at baseline to 56.1 ml at 5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: